NBTXR3 Activated by Radiotherapy for Patients With Advanced Cancers Treated With An Anti-PD-1 Therapy

Conditions

• Radiotherapy
• Immunotherapy
• Microsatellite Instability-High Solid Malignant Tumour
• Metastasis From Malignant Tumor of Liver
• Squamous Cell Carcinoma of Head and Neck
• Metastasis From Malignant Tumor of Cervix
• Metastatic Renal Cell Carcinoma
• Metastasis From Malignant Melanoma of Skin (Disorder)
• Metastatic Triple-Negative Breast Carcinoma
• Metastatic NSCLC
• Metastasis From Malignant Tumor of Bladder (Disorder)

Interventions

• DRUG: NBTXR3
• RADIATION: SABR
• DRUG: Nivolumab
• DRUG: Pembrolizumab

Sponsor

Nanobiotix